Winton Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-37,255
| Closed | -$184K | – | 768 |
|
|
2023
Q1 | $184K | Buy |
37,255
+2,251
| +6% | +$11.1K | 0.01% | 912 |
|
|
2022
Q4 | $220K | Buy |
35,004
+1,722
| +5% | +$10.8K | 0.01% | 855 |
|
|
2022
Q3 | $359K | Sell |
33,282
-5,366
| -14% | -$57.9K | 0.02% | 737 |
|
|
2022
Q2 | $441K | Buy |
38,648
+8,178
| +27% | +$93.3K | 0.02% | 722 |
|
|
2022
Q1 | $278K | Buy |
30,470
+5,911
| +24% | +$53.9K | 0.01% | 836 |
|
|
2021
Q4 | $366K | Sell |
24,559
-5,453
| -18% | -$81.3K | 0.02% | 772 |
|
|
2021
Q3 | $771K | Sell |
30,012
-1,654
| -5% | -$42.5K | 0.04% | 635 |
|
|
2021
Q2 | $826K | Buy |
31,666
+11,757
| +59% | +$307K | 0.04% | 638 |
|
|
2021
Q1 | $703K | Sell |
19,909
-2,535
| -11% | -$89.5K | 0.04% | 680 |
|
|
2020
Q4 | $566K | Sell |
22,444
-66,719
| -75% | -$1.68M | 0.04% | 727 |
|
|
2020
Q3 | $3.36M | Buy |
89,163
+35,123
| +65% | +$1.32M | 0.11% | 277 |
|
|
2020
Q2 | $2.31M | Buy |
54,040
+5,832
| +12% | +$250K | 0.06% | 582 |
|
|
2020
Q1 | $937K | Buy |
48,208
+6,634
| +16% | +$129K | 0.02% | 823 |
|
|
2019
Q4 | $1.08M | Buy |
+41,574
| New | +$1.08M | 0.02% | 1040 |
|